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Abstract
A one-pot synthesis of various GABA amides has been demostrated, employing the nucleophilic 
addition of primary and secondary amines across the double bond of cyclopropene-3-
carboxamides, followed by ring-opening of the resulting donor-acceptor cyclopropanes and 
subsequent in situ reduction of enamine (imine) intermediates.
Graphical abstract
γ-Aminobutyric acid (GABA) is the chief inhibitory neurotransmitter in the mammalian 
central nervous system playing a principal role in reducing neuronal excitability,1 and is a 
species of immense importance for modern bioorganic and medicinal chemistry. This motif 
is omnipresent in natural products, including Bistramide A2 and cyclic oligopeptides 
Microsclerodermins3 and Unguisins.4 GABA derivatives are also widely used in numerous 
over-the-counter and prescription medicinal agents, such as Noofen (Phenibut),5 Picamilon,6 
Lioresal (Baclophen), Lyrica (Pregabalin)7 or anti-arthritic drug Trocade (Cipemastat)8 
(Figure 1).
In our studies9 of donor-acceptor cyclopropanes (DAC),10 we investigated the possibility to 
access substituted GABA derivatives 5 via the ring opening of DAC 1 (Scheme 1). The 
propensity of DACs toward ring cleavage is proportional to polarization of the C–C bond 
between electron-donating (EDG) and electron-withdrawing (EWG) groups. The requisite 
polarization is commonly achieved through installation of strong EWGs, typically two ester 
groups, additionally activated by a Lewis acid (“pull” strategy), which leads to products with 
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an “extra” carboxylate moiety at the α-carbon. In our recent report9 we proposed the 
possibility to employ an alternative “push” strategy by taking advantage of our formal 
nucleophilic substitution methodology that allows for installation of various N-moieties in 
the cyclopropane ring. Herein we demonstrate the proof of concept and employment of this 
strategy toward synthesis of GABA amide derivatives.
The above-mentioned formal nucleophilic substitution of halocyclopropanes 69 provides 
convenient access to various cyclopropylamine derivatives 11, including carboxamides and 
sulphonamides of trans-β-aminocyclopropanecarboxylic acid (β-ACC), N-
cyclopropylhetaryls and N-cyclopropylanilines (Scheme 2).9,11 These reactions proceed via 
a base-driven nucleophilic addition across the double bond of conjugate cyclopropene 
10.12,13 However, attempts to isolate hydroamination products resulting from the addition of 
electron-rich amine derivatives to the in situ generated, very electrophilic 1-substituted 
cyclopropenes 10 were unsuccessful. Small amount of water generated as by-product upon 
dehydrohalogenation of 6 in the presence of KOH resulted in a rapid, amine-mediated ring-
opening hydration of intermediate cyclopropene 10 affording aldehyde 12 (Scheme 2).9 
Furthermore, nitrogen nucleophiles do not easily add to less electrophilic, non-conjugate 
3,3-disubstituted cyclopropenes 7 under conditions used for generation thereof.14 This 
reaction was totally suppressed by a much more facile addition of an alkoxide (employed as 
a base for dehydrohalogenation step), to afford cyclopropanol ether 9. Thus, employment of 
a stable, isolated cyclopropenes 715 was envisaged as an alternative approach to 
hydroamination that could be carried out under alcohol- and/or water-free conditions. It was 
anticipated that the addition of an electron-rich amino group would help trigger the desired 
bond cleavage in intermediate 1. The resulting zwitterionic intermediate 2, in the presence of 
a proton source, would be stabilized in a form of imine 3 (if derived from primary amine 8) 
or enamine 4, respectively. Species 3 or 4 can subsequently be reduced in situ to give 
GABA amide 5 (Scheme 1), or be employed as electrophilic or nucleophilic moiety in 
various imine or enamine chemistry.
Accordingly, we exposed neat N,N-diethyl-1-methylcycloprop-2-ene-1-carboxamide (7a)15 
to diethylamine (8a, 3.0 equiv.) at various temperatures to monitor the ring opening. It was 
found that heating the mixture at 100 °C allowed for complete and clean ring cleavage. GC 
analysis of crude reaction mixtures showed a single product peak, attributed to enamine 4aa. 
Next, the crude mixture was treated with borohydride (NaBH4 or NaBH(OAc)3) in 
dichloromethane to afford the target amide 5aa as a single product in good yield (Table 1, 
entry 1). Interestingly, under similar conditions, diisopropylamine (8b) did not react at all, 
leaving cyclopropene 7a intact even after extended heating at 125 °C. Apparently, this bulky 
amine was insufficiently nucleophilic to enable the hydroamination step (entry 2). In 
contrast, cyclic secondary amines, such as pyrrolidine (8c), morpholine (8d), N-ethyl- (8e), 
and N-benzylpiperazines (8f) afforded GABA amides 5ad-5af in good yields (entries 3–6). 
N,N-Diisopropyl-1-methylcycloprop-2-ene-1-carboxamide (7b)15 and (1-
methylcycloprop-2-en-1-yl)(pyrrolidin-1-yl)methanone (7c)15 proved to be similarly 
efficient as 7a with a number of secondary amines (entries 7–12). Reaction with primary 
amines, such as phenethylamine (8g), benzylamine (8h), and n-butylamine (8j), also 
proceeded uneventfully, although somewhat more sluggishly (entries 13, 14, 16–19). It was 
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also necessary to raise the temperature to 140 °C to drive the reaction with aniline (8i) to 
complete conversion (entry 15).
Finally, a possibility to induce a diastereoselective ring cleavage upon addition of chiral 
amines was probed by reacting cyclopropene 7a with α-phenylethylamine (8k). 
Unfortunately, transfer of asymmetric information from a remote stereogenic center was not 
efficient, and the corresponding adduct 5ak was produced as a 1:1 mixture of two 
diastereomers (entry 20).
Conclusions
In conclusion, we have successfully employed an alternative “push” strategy for ring 
opening of “push-pull” cyclopropanes generated in situ via the unassisted nucleophilic 
addition of electron-rich amines across the double bond of cyclopropene-3-carboxamides. 
This concept was utilized in efficient one-pot synthesis of GABA derivatives. Further 
investigations of this transformation are currently underway in our laboratories, which 
include (a) exploring the possibility of controlling the diastereoselectivity of small ring 
cleavage upon addition of chiral amines, assisted by Lewis acidic chelating agents; (b) 
investigating regio- and stereoselectivity of ring cleavage in 1,3,3-trisubstituted chiral 
cyclopropenes en route to chiral GABA derivatives possessing several contiguous 
stereogenic centers; (c) intercepting imine species 3 in diastereoselective reactions with C-
nucleophiles. The results on these studies will be reported in due course.
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